300977.SZ
深圳瑞捷
SZSE · M 科研服务 · CN
CNY 16.10
−1.71%Year over year
Reported trailing growth
- Revenue
- +4.6%
- EBITDA
- —
- EBIT
- +182.7%
- EPS
- +190.2%
- Free cash flow
- +125.1%
- Operating cash flow
- +270.3%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -6.5%
- EBITDA
- +19.5%
- EBIT
- +25.4%
- Net income
- +23.9%
- EPS
- +26.0%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026